StrideBio, Inc: Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer.The newly created role will see Dr McIntyre oversea the translational development of the company's research-stage gene therapy programs. This includes regulatory filings, initiating early clinical studies and starting Investigational New Drug enabling preclinical studies.read more